Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis

Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia

(2013) Julio Ramirez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Breakthrough Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae during Combination Therapy with Colistin and Tigecycline

(2012) Sun Young Cho et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increased Susceptibility of Pseudomonas aeruginosa to Macrolides and Ketolides in Eukaryotic Cell Culture Media and Biological Fluids Due to Decreased Expression of oprM and Increased Outer-Membrane Permeability

(2012) Julien M. Buyck et al.   CLINICAL INFECTIOUS DISEASES

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

(2012) R. G. Wunderink et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of Tigecycline versus Ceftriaxone Plus Metronidazole for the Treatment of Complicated Intra-Abdominal Infections: Results from a Randomized, Controlled Trial

(2012) Niels Qvist et al.   Surgical Infections

Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan

(2011) Yin-Ching Chuang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis

(2011) Efthimia Tasina et al.   LANCET INFECTIOUS DISEASES

Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus

(2010) Kamal M.F. Itani et al.   AMERICAN JOURNAL OF SURGERY

Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial

(2010) Zhangjing Chen et al.   BMC INFECTIOUS DISEASES

A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections

(2010) S. Towfigh et al.   CLINICAL MICROBIOLOGY AND INFECTION

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)

(2009) et al.   EUROPEAN HEART JOURNAL

Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia

(2009) R. Mokabberi et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia

(2009) Cristina Tanaseanu et al.   BMC Pulmonary Medicine

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

(2008) Cristina Tanaseanu et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

(2008) Carlos Bergallo et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Linezolid for the treatment of infections caused by Gram-positive pathogens in China

(2008) Dong-fang Lin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS